Short answer
BrightSpring Health Services, Inc. (BTSG) filed an 8-K current report with the SEC on October 30, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). BrightSpring issued fiscal Q3 2026 results for the quarter ended September 30, 2026.
BrightSpring Health Services, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- BrightSpring issued fiscal Q3 2026 results for the quarter ended September 30, 2026
- Full financial details and management commentary available in Exhibit 99.1, the accompanying earnings release
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $4,213M, up 26.4%, with net income from continuing operations rising to $101M from $38M
- Adjusted EBITDA $228M, up 42.0%, outpacing revenue growth and signaling operating leverage
- Pharmacy revenue $3,732M, up 26%, driven by revenue per prescription increasing 24% to $340.86
- Leverage improved to 1.79x from 2.15x, supported by $810.9M in divestiture proceeds and debt repayments
- 2026 guidance increased to revenue $15,900M-$16,125M and Adjusted EBITDA $850M-$860M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other BrightSpring Health Services, Inc. 8-K filings
Get the next BTSG 8-K as it lands
Follow BTSG for push alerts, or ask the research agent what this filing means.